Literature DB >> 17262858

Airway hyperresponsiveness and acute chest syndrome in children with sickle cell anemia.

Karl P Sylvester1, Richard A Patey, Gerrard F Rafferty, David Rees, Swee Lay Thein, Anne Greenough.   

Abstract

To determine the occurrence and magnitude of airway hyperresponsiveness (AHR) in children with sickle cell anemia (SCA) who had or had not had acute chest syndrome (ACS) episodes. A subsidiary aim was to determine whether cold air and exercise challenge testing gave similar results in children with SCA. AHR would be greater in SCA children who had had an ACS episode compared to those who had not. Prospective observational study. Forty-two SCA children (median age of 11.5 [range 6.1-16.8] years); 12 children had been previously hospitalized for an ACS episode. AHR was assessed by the change in forced expiratory volume in 1 sec (FEV1) to a cold air challenge and in a subset of the children to an exercise challenge. A positive result to either challenge was deemed to have occurred if the FEV1 fell by at least 10% from the pre-challenge baseline. The magnitude of change in FEV1 following the cold air challenge was similar in children who had or had not had an ACS episode. Six children had a positive response to the cold air challenge (AHR); none had had an ACS hospitalization. Similar proportions of children responded to the cold air and exercise challenge and the magnitude of response to the two tests was similar. Some children, however, responded only to a cold air challenge and others only to an exercise challenge. SCA children who had had an ACS hospitalization episode compared to those who had not were not more likely to respond to a cold air challenge. Importantly, if AHR is to be correctly diagnosed, some SCA children will require to undergo both cold air and exercise challenge testing. 2007 Wiley-Liss, Inc.

Entities:  

Mesh:

Year:  2007        PMID: 17262858     DOI: 10.1002/ppul.20571

Source DB:  PubMed          Journal:  Pediatr Pulmonol        ISSN: 1099-0496


  12 in total

Review 1.  Asthma morbidity and treatment in children with sickle cell disease.

Authors:  Samuel O Anim; Robert C Strunk; Michael R DeBaun
Journal:  Expert Rev Respir Med       Date:  2011-10       Impact factor: 3.772

2.  Asthma Screening in Pediatric Sickle Cell Disease: A Clinic-Based Program Using Questionnaires and Spirometry.

Authors:  Sara C Sadreameli; Rachel O Alade; Peter J Mogayzel; Sharon McGrath-Morrow; John J Strouse
Journal:  Pediatr Allergy Immunol Pulmonol       Date:  2017-12-01       Impact factor: 1.349

3.  Placenta growth factor augments airway hyperresponsiveness via leukotrienes and IL-13.

Authors:  Marthe-Sandrine Eiymo Mwa Mpollo; Eric B Brandt; Shiva Kumar Shanmukhappa; Paritha I Arumugam; Swati Tiwari; Anastacia Loberg; Devin Pillis; Tilat Rizvi; Mark Lindsey; Bart Jonck; Peter Carmeliet; Vijay K Kalra; Timothy D Le Cras; Nancy Ratner; Marsha Wills-Karp; Gurjit K Khurana Hershey; Punam Malik
Journal:  J Clin Invest       Date:  2015-12-21       Impact factor: 14.808

4.  Respiratory syncytial virus and seasonal influenza cause similar illnesses in children with sickle cell disease.

Authors:  Sara Christina Sadreameli; Megan E Reller; David G Bundy; James F Casella; John J Strouse
Journal:  Pediatr Blood Cancer       Date:  2014-01-31       Impact factor: 3.167

5.  Methacholine challenge in children with sickle cell disease: a case series.

Authors:  Robert C Strunk; Michael Scott Brown; Jessica H Boyd; Pamela Bates; Joshua J Field; Michael R DeBaun
Journal:  Pediatr Pulmonol       Date:  2008-09

6.  Wheezing and asthma are independent risk factors for increased sickle cell disease morbidity.

Authors:  Jeffrey A Glassberg; Annie Chow; Juan Wisnivesky; Ronald Hoffman; Michael R Debaun; Lynne D Richardson
Journal:  Br J Haematol       Date:  2012-09-12       Impact factor: 6.998

7.  Factors predicting future ACS episodes in children with sickle cell anemia.

Authors:  Michael R DeBaun; Mark Rodeghier; Robyn Cohen; Fenella J Kirkham; Carol L Rosen; Irene Roberts; Ben Cooper; Janet Stocks; Olu Wilkey; Baba Inusa; John O Warner; Robert C Strunk
Journal:  Am J Hematol       Date:  2014-08-27       Impact factor: 10.047

8.  Unraveling restrictive chronic lung disease in sickle cell disease.

Authors:  Shilpa Jain; Mark T Gladwin; Enrico M Novelli
Journal:  Int J Tuberc Lung Dis       Date:  2013-09       Impact factor: 2.373

Review 9.  How I treat hypoxia in adults with hemoglobinopathies and hemolytic disorders.

Authors:  Evans M Machogu; Roberto F Machado
Journal:  Blood       Date:  2018-09-11       Impact factor: 22.113

10.  Asthma in sickle cell disease: implications for treatment.

Authors:  Kathryn Blake; John Lima
Journal:  Anemia       Date:  2011-03-03
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.